3Billion

3Billion EBIT Margin

The EBIT Margin (Operating Margin) of 3Billion (394800.KQ) as of Oct 16, 2026 is -50.30 %. In the previous year, EBIT Margin (Operating Margin) was -128.53 % — a change of -60.87% (higher).

EBIT Margin

-50.30 %

YoY

-60.87%

Last updated:

EBIT Margin (Operating Margin) of 3Billion is 2025 -50.30 % . EBIT Margin (Operating Margin) of 3Billion was 2024 -128.53 % . It decreases by -60.87% higher compared to the previous year.

For 3Billion, the operating (EBIT) margin of -50.3% is up versus -1,216.4% a few years ago.

The 3Billion EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2021
-1,216.38 KRW
Jan 1, 2022
-992.68 KRW
Jan 1, 2023
-305.91 KRW
Jan 1, 2024
-128.53 KRW
Jan 1, 2025
-50.30 KRW
The 3Billion EBIT Margin history
YEAREBIT MarginYoY
-50.30 %-60.87%
-128.53 %-57.98%
-305.91 %-69.18%
-992.68 %-18.39%
-1,216.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

3Billion Stock analysis

What does 3Billion do? 3Billion Inc is a company based in Seoul, South Korea, with its headquarters located in the city. The company has a ticker symbol of 394800.KQ and an ISIN of KR7394800007. It went public through an IPO on November 14, 2024. 3Billion Inc operates in the field of genetic testing services, focusing on rare genetic disease diagnostic testing. The company is involved in the research and development of technology designed to automatically assess the pathogenicity of various genetic variants within the genome. Its website is https://3billion.io/. The company's sector and industry classifications are listed as N/A, indicating that these details are not specified in the provided information. No additional details regarding founding year, key personnel, acquisitions, or specific financial figures are available from the given data. The company's primary activities center around the provision of diagnostic services and technological innovation in genetic analysis, aiming to support medical professionals and patients through advanced genetic testing solutions. 3Billion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 3Billion stock

EBIT Margin (Operating Margin) of 3Billion is -50.30 % in 2025.

EBIT Margin (Operating Margin) of 3Billion changed from -128.53 % to -50.30 %, representing a -60.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) 3Billion since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s 3Billion with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — 3Billion

All Key Metrics — 3Billion